Employees

Gerald Hecken-Meissner joined GMP-Orphan in 2018. He brings more than 30 years of international pharmaceutical industry experience in commercialization, market access, strategic and business [...]

Louise is responsible for leading the Clinical Development strategy, delivering the Clinical Research programs and to define and monitor the Quality Management System (QMS). Louise joined [...]

A graduate of EDHEC Business School, Mr. Morin began his career in 2005 at MAZARS, as a Financial Auditor for Private Equity Firms. In 2009, he joined CDC Enterprises, a Funds Management company, [...]

Fred Marin is a French entrepreneur since more than 15 years, in med tech, API development and manufacturing, as well as drug development. In 2011, he co-founded gmp-orphan SA (“GMPO”), in which [...]

Shahzad Malik has a strong background in science, clinical medicine, and international finance. He gained an MA in Physiological Sciences from Oxford University and an MD from Cambridge [...]

Chahra Louafi is Investment Director and head of the fund for biotherapies and rare diseases at Bpifrance (previously CDC Entreprises). Prior to joining CDC Entreprises, she was in charge of [...]

MD FFPM FRCOG Laurence has spent more than 25 years in senior positions in early and late stage clinical development, regulatory and medical affairs. Laurence graduated in medicine from King’s [...]

Tim Morley has over 25 years experience in discovery, regulatory safety and development with Pharmaceutical and Medical Device companies. Tim is a Board Certified Toxicologist and Fellow of the [...]

Serena Baldissera joined GMP-Orphan in 2017, with over 17 years of industry experience in Regulatory Affairs in international settings. Serena has held positions of increasing responsibility in [...]

Naseem Amin joined GMP-Orphan in 2016. He brings 26 years of trans-Atlantic industry experience in R and D, corporate development, business development, and marketing. Naseem most recently served [...]